Health Canada inspection
Novacyl Wuxi Pharmaceutical Co. Ltd.: Health Canada inspection of Sep 15, 2017
Health Canada · GMP · rating C
Key facts
| Establishment | Novacyl Wuxi Pharmaceutical Co. Ltd. |
|---|---|
| City | Wuxi |
| Province | Jiangsu |
| Country | China |
| Program | GMP |
| Start date | Sep 11, 2017 |
| End date | Sep 15, 2017 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.